<?xml version="1.0" encoding="UTF-8"?>
<p>In another randomized, double-blind, placebo-controlled trial in the US, 821 asymptomatic participants were randomly assigned to receive either placebo or hydroxychloroquine 4 days after exposure to someone with confirmed COVID-19. The study found that hydroxychloroquine did not prevent illness related to COVID-19 or confirmed infection when used as postexposure prophylaxis within this timeframe (
 <xref rid="B93" ref-type="bibr">93</xref>).
</p>
